Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.56 |
| ▸ | HCRTR1 | O43613 | 17/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 16/20 | 0.41 |
| ▸ | CSF1R | P07333 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8287215 | 0.89 | PDE11A (0.61) | PDE11AHCRTR1HCRTR2 | |
| SCHEMBL8287101 | 0.89 | PDE11A (0.60) | PDE11AHCRTR1HCRTR2CSF1RALDH1A1 | |
| SCHEMBL8287168 | 0.89 | PDE11A (0.56) | PDE11AHCRTR1HCRTR2 | |
| SCHEMBL8287224 | 0.87 | PDE11A (0.58) | PDE11AHCRTR1HCRTR2 | |
| SCHEMBL8287105 | 0.85 | PDE11A (0.53) | PDE11AHCRTR1HCRTR2CSF1RMEN1 | |
| SCHEMBL8286349 | 0.85 | PDE11A (0.61) | PDE11AHCRTR1HCRTR2MEN1GAA | |
| SCHEMBL8287819 | 0.84 | PDE11A (0.53) | PDE11ACSF1RMEN1ALDH1A1GAA | |
| SCHEMBL8286353 | 0.83 | PDE11A (0.57) | PDE11AHCRTR1HCRTR2MEN1GAA | |
| SCHEMBL8287155 | 0.83 | PDE11A (0.59) | PDE11AHCRTR1HCRTR2MEN1ALDH1A1 | |
| SCHEMBL8286350 | 0.82 | PDE11A (0.58) | PDE11AHCRTR1HCRTR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005091857-A2 | 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS | BAYER PHARMACEUTICALS CORPORATION (US) | 2005-10-06 | — | — | WO | disclosed |
| WO-2003027112-A1 | 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS | BAYER PHARMACEUTICALS CORPORATION (US) | 2003-04-03 | — | — | WO | disclosed |